Fundraising Fox

Ansa Biotechnologies

YC W20 ↗

Emeryville, US · Founded 2018 · Delaware corporation · 72 employees · 9 known investors

ansabio.com ↗

Ansa provides an enzymatic DNA synthesis platform that directly synthesizes complex sequences up to 900 bp and delivers constructs up to 50 kb without assembly-based methods. It serves scientists in gene and cell therapies, antibody discovery, CDMOs, and agrigenomics.

BiotechDeep TechHealthtechSynthetic Biologyin /ansabio@ansabioycombinator.com ↗

Founders & leadership· Y Combinator alumni (W20)

DLDan Lin-Arlow
Dan Lin-ArlowinFounder
SPSebastian Palluk
Sebastian PallukinFounder
JT
Jason T. GammackExecutive Officer, Director
YD
Yanniv DoroneDirector
DL
Daniel Lin-ArlowExecutive Officer, Director
CZ
Chenny ZhangDirector
MM
Matthew McManusDirector
DH
Daniel Hillel Lin-ArlowExecutive Officer, Director

Investors · 9

Carbon SiliconCarson City · $100K – $500Kvia Nish Bhat · inferred
Dauntless VenturesHolladay
Fifty YearsSan Francisco · $250K – $2M
MetaplanetTallinn · $500K – $10M
Y CombinatorSan Francisco · $500K
Fall Line CapitalreportedSan Francisco
Horizons VenturesreportedHong Kong · $1M – $110M
HumboldtreportedNew York · $100K – $5M
RA CapitalreportedBoston

Reported raises · per SEC filings

Form D private placements
▶$46.4MraisedDec 2025 · 41 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jason T. GammackExecutive Officer, Director
  • Yanniv DoroneDirector
  • Daniel Lin-ArlowExecutive Officer, Director
  • Chenny ZhangDirector
  • Matthew McManusDirector
  • Sebastian PallukExecutive Officer
Offering amount
$56.9M
Amount sold
$46.4M
First sale
Jun 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$68MraisedMay 2022 · 28 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Daniel Lin-ArlowExecutive Officer, Director
  • Sebastian PallukExecutive Officer, Director
  • Lily LiDirector
Offering amount
$76.7M
Amount sold
$68M
First sale
Mar 2022
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedOct 2021 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Sebastian PallukExecutive Officer, Director
  • Daniel Lin-ArlowExecutive Officer, Director
Offering amount
$5M
Amount sold
$5M
First sale
Oct 2021
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.7MraisedJul 2020 · 24 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Sebastian PallukExecutive Officer, Director
  • Daniel Hillel Lin-ArlowExecutive Officer, Director
Offering amount
$9.2M
Amount sold
$4.7M
First sale
Jun 2020
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news